Overview
A Prospective randomized trial with a primary objective to investigate the effect ofprdenisolone treatment in acute interstitial nephritis
Eligibility
Inclusion Criteria:
- Kidney biopsy with AIN Clinical AIN Acute renal failure
Exclusion Criteria:
- Not able to give informed consent immunosuppressive treatment autoimmune disease allergi or intolerence to prednisone pregnancy or nursing active malignant disease CKD stage 4 or 5 Previous participation AIN with glomerulonephritis, sarcoidosis or inherited interstitial disease